Nesiritide in perspective: evolving approaches to the management of acute decompensated heart failure.

@article{Mills2003NesiritideIP,
  title={Nesiritide in perspective: evolving approaches to the management of acute decompensated heart failure.},
  author={Roger M Mills and Robert E. Hobbs},
  journal={Drugs of today},
  year={2003},
  volume={39 10},
  pages={767-74}
}
Nesiritide is currently indicated for the management of acute decompensated heart failure defined by the presence of volume overload and dyspnea at rest or with minimal activities. Hypotension and cardiogenic shock are the major contraindications to nesiritide use. The recommended dosing schedule is a 2 micro g/kg bolus followed by a 0.01 micro g/kg/min… CONTINUE READING